CAMP earnings date and last-quarter result: next report 2026-08-13, last quarter miss, P/E -1.37. Updated 2026-07-23.
CAMP4 Therapeutics (CAMP) Research Hub
CAMP4 Therapeutics (CAMP) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 3.21 USD (-2.73%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.37, market cap 0.07B. This hub links to the full technical, earnings and options research available for CAMP.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.21 USD (-2.73%) |
| 52-week range | 2.9 USD – 6 USD |
| Trend regime | Range |
| 14-day RSI | 23.8 (Oversold) |
| Trailing P/E | -1.37 |
| Market cap | 0.07B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for CAMP
Covered Call on CAMP: how it works, illustrative setup around the real 3.21 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CAMP: how it works, illustrative setup around the real 3.21 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CAMP: how it works, illustrative setup around the real 3.21 USD price, max profit/loss, breakeven and when to use it. Educational.
CAMP technical analysis: range, last 3.21 USD, RSI 23.8, 52w range 2.9 USD–6 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is CAMP in?
CAMP4 Therapeutics (CAMP) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is CAMP in an uptrend or downtrend?
As of 2026-10-26, CAMP is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CAMP's trailing P/E ratio?
CAMP's trailing P/E is -1.37, with a market cap of 0.07B. See the earnings research page for full valuation detail.
When does CAMP next report earnings?
CAMP is next scheduled to report earnings on 2026-08-13.